Similar to other GLP-1 medications, tirzepatide dosing gradually increases
Its very unusual to see the extended shortage of a multi-billion dollar drug, leading to the funky dynamics were seeing DTC telehealth players (and in-person med spas, other wellness facilities) want to maximize their economics by expanding access to acquire/grow subscriber bases
Glucagon-like peptide-1 receptor agonist use and renal impairment: a retrospective analysis of an electronic health records database in the U.S
This is worth monitoring and discussing with your provider if it occurs
Emerging evidence underscores the centrality of FA metabolism perturbations in driving disease progression, from hyperuricemia-triggered crystal deposition to sustained NLRP3 inflammasome activation, ultimately forming a self-perpetuating metabolism-immunity axis
and food insecurity caused by global climate change, which drives people towards cheap, highly processed foods